The proposed bill establishes a task force to study the sale of over-the-counter diet pills and dietary supplements for weight loss or muscle building in the state. This task force will consist of 11 members, including representatives from various state departments such as the Commission on Women, Children, Seniors, Equity and Opportunity, the Department of Consumer Protection, and the Department of Public Health. The task force is mandated to submit a report by January 1, 2027, detailing its findings on the safety of these products, potential restrictions on sales to minors, and best practices from other states regarding their regulation.

In addition to the task force, the bill amends Section 20-579a of the general statutes to enhance protections for prescribers of reproductive health care and gender-affirming health care services. The amendments prohibit the Commissioner of Consumer Protection and the Commission of Pharmacy from denying licenses or imposing disciplinary actions based on adverse actions taken by other states or federal entities, as long as these actions pertain to services permitted under state law. Furthermore, the bill allows prescriptions related to reproductive and gender-affirming health care to include the name and address of the prescribing and dispensing facility instead of the prescriber’s name and signature, enhancing privacy for practitioners. The effective date for these provisions is set for October 1, 2026.

Statutes affected:
Raised Bill: 20-614, 20-617
GL Joint Favorable Substitute: 20-614, 20-617
File No. 216: 20-614, 20-617